| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.03 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |